Researchers of the Research Programme on Biomedical Informatics (GRIB) from UPF and Hospital del Mar Medical Research Institute (IMIM) in Barcelona, Spain, have identified behavioral and linguistic changes in tweets in Spanish ...
Feb 15, 2021
0
6
More than 20 million people in the U.S. suffer neuropathic pain. At least 25% of those cases are classified as unexplained and considered cryptogenic sensory polyneuropathy (CSPN). There is no information to guide a physician's ...
Oct 15, 2020
0
172
A study published in Molecular Psychiatry shows that patient-derived adult stem cells can be used to model major depressive disorder and test how a patient may respond to medication.
Jun 11, 2020
0
109
More than 14 million Americans suffer from clinical depression, yet one in three doesn't experience relief from approved antidepressant drugs. A new treatment approach involving drugs called neurosteroids is on the horizon, ...
Nov 1, 2019
1
161
Taking antidepressants or opioids more than doubles the risk of a fall and hip fracture in older people, according to a paper published today in Australian Prescriber.
Jun 3, 2019
0
5
A new study published in the current issue of Psychotherapy and Psychosomatics sheds new light on long-term studies with antidepressant drugs. The higher occurrence of relapse in the groups assigned to placebo instead of ...
Apr 11, 2019
0
9
Ketamine has been intensively studied in psychiatry in recent years. Unlike traditional antidepressants, ketamine brings about its antidepressant effects very rapidly. A recent study conducted at the University of Helsinki, ...
Mar 27, 2019
0
62
Antidepressant prescribing in England rose relative to other types of drug in the immediate aftermath of the results of the European Union referendum in June 2016, when Britons voted in favor of Brexit, reveals research published ...
Nov 20, 2018
0
2
Winter is upon us. And with it comes the annual worsening of depressive symptoms. Sadly, in the United States, suicide continues to claim more lives than firearms, and suicide rates are increasing in nearly all states. The ...
Nov 14, 2018
0
7
Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment. The results of ...
Oct 29, 2018
0
21
